136 related articles for article (PubMed ID: 21897819)
1. Stimulation of Wild-Type, F508del- and G551D-CFTR Chloride Channels by Non-Toxic Modified pyrrolo[2,3-b]pyrazine Derivatives.
Dannhoffer L; Billet A; Jollivet M; Melin-Heschel P; Faveau C; Becq F
Front Pharmacol; 2011; 2():48. PubMed ID: 21897819
[TBL] [Abstract][Full Text] [Related]
2. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels.
Noel S; Faveau C; Norez C; Rogier C; Mettey Y; Becq F
J Pharmacol Exp Ther; 2006 Oct; 319(1):349-59. PubMed ID: 16829626
[TBL] [Abstract][Full Text] [Related]
3. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
[TBL] [Abstract][Full Text] [Related]
4. Effect of VX-770 (ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells.
Vachel L; Norez C; Becq F; Vandebrouck C
J Cyst Fibros; 2013 Dec; 12(6):584-91. PubMed ID: 23757361
[TBL] [Abstract][Full Text] [Related]
5. Junctional abnormalities in human airway epithelial cells expressing F508del CFTR.
Molina SA; Stauffer B; Moriarty HK; Kim AH; McCarty NA; Koval M
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(5):L475-87. PubMed ID: 26115671
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a.
Bertrand J; Boucherle B; Billet A; Melin-Heschel P; Dannhoffer L; Vandebrouck C; Jayle C; Routaboul C; Molina MC; Décout JL; Becq F; Norez C
Eur Respir J; 2010 Aug; 36(2):311-22. PubMed ID: 20110398
[TBL] [Abstract][Full Text] [Related]
7. Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.
Bose SJ; Bijvelds MJC; Wang Y; Liu J; Cai Z; Bot AGM; de Jonge HR; Sheppard DN
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L71-L86. PubMed ID: 30969810
[TBL] [Abstract][Full Text] [Related]
8. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
10. Rescue of functional F508del cystic fibrosis transmembrane conductance regulator by vasoactive intestinal peptide in the human nasal epithelial cell line JME/CF15.
Rafferty S; Alcolado N; Norez C; Chappe F; Pelzer S; Becq F; Chappe V
J Pharmacol Exp Ther; 2009 Oct; 331(1):2-13. PubMed ID: 19584307
[TBL] [Abstract][Full Text] [Related]
11. Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel.
Becq F; Mettey Y; Gray MA; Galietta LJ; Dormer RL; Merten M; Métayé T; Chappe V; Marvingt-Mounir C; Zegarra-Moran O; Tarran R; Bulteau L; Dérand R; Pereira MM; McPherson MA; Rogier C; Joffre M; Argent BE; Sarrouilhe D; Kammouni W; Figarella C; Verrier B; Gola M; Vierfond JM
J Biol Chem; 1999 Sep; 274(39):27415-25. PubMed ID: 10488073
[TBL] [Abstract][Full Text] [Related]
12. Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.
Liu J; Bihler H; Farinha CM; Awatade NT; Romão AM; Mercadante D; Cheng Y; Musisi I; Jantarajit W; Wang Y; Cai Z; Amaral MD; Mense M; Sheppard DN
Br J Pharmacol; 2018 Apr; 175(7):1017-1038. PubMed ID: 29318594
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
Cai Z; Taddei A; Sheppard DN
J Biol Chem; 2006 Jan; 281(4):1970-7. PubMed ID: 16311240
[TBL] [Abstract][Full Text] [Related]
14. A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
Boucherle B; Bertrand J; Maurin B; Renard BL; Fortuné A; Tremblier B; Becq F; Norez C; Décout JL
Eur J Med Chem; 2014 Aug; 83():455-65. PubMed ID: 24992073
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004.
Dérand R; Bulteau-Pignoux L; Becq F
J Membr Biol; 2003 Jul; 194(2):109-17. PubMed ID: 14502435
[TBL] [Abstract][Full Text] [Related]
16. Quantitative phase imaging to study transmembrane water fluxes regulated by CFTR and AQP3 in living human airway epithelial CFBE cells and CHO cells.
Llinares J; Cantereau A; Froux L; Becq F
PLoS One; 2020; 15(5):e0233439. PubMed ID: 32469934
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the cystic fibrosis transmembrane conductance regulator Cl
Wang Y; Cai Z; Gosling M; Sheppard DN
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L846-L857. PubMed ID: 30136610
[TBL] [Abstract][Full Text] [Related]
18. Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells.
Favia M; Mancini MT; Bezzerri V; Guerra L; Laselva O; Abbattiscianni AC; Debellis L; Reshkin SJ; Gambari R; Cabrini G; Casavola V
Am J Physiol Lung Cell Mol Physiol; 2014 Jul; 307(1):L48-61. PubMed ID: 24816489
[TBL] [Abstract][Full Text] [Related]
19. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
[TBL] [Abstract][Full Text] [Related]
20. Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.
Boinot C; Jollivet Souchet M; Ferru-Clément R; Becq F
J Pharmacol Exp Ther; 2014 Sep; 350(3):624-34. PubMed ID: 24970923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
